A CMO's Roadmap To Net Zero: Adding Value Through Sustainable Practices
Achieving net zero has become a paramount goal for industries worldwide, including the pharmaceutical industry. For CMOs providing manufacturing services of active pharmaceutical ingredients (APIs) and intermediates, which require large-scale chemical synthesis processes, leveraging sustainable technologies and operations to optimize waste management is crucial for achieving net zero emissions.
However, CMOs must not only consider emissions created by internal operations but also across the value chain. Collaborative efforts with suppliers, sustainable sourcing practices, and innovation in product lifecycle management play pivotal roles in a comprehensive approach to reducing a CMO’s carbon footprint.
Learn how ESTEVE is navigating the path to net zero by aligning itself with planet-conscious talent and partners and review key considerations for reducing carbon emissions across all stages of the development and manufacturing value chain.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.